| 000 | 01839 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517001400.0 | ||
| 264 | 0 | _c20150825 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1432-1238 | ||
| 024 | 7 |
_a10.1007/s00134-014-3524-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aForel, Jean-Marie | |
| 245 | 0 | 0 |
_aType III procollagen is a reliable marker of ARDS-associated lung fibroproliferation. _h[electronic resource] |
| 260 |
_bIntensive care medicine _cJan 2015 |
||
| 300 |
_a1-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 |
_aBronchoalveolar Lavage Fluid _xchemistry |
| 650 | 0 | 4 |
_aCollagen Type III _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibroblasts _xpathology |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPulmonary Fibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aRespiratory Distress Syndrome _xcomplications |
| 700 | 1 | _aGuervilly, Christophe | |
| 700 | 1 | _aHraiech, Sami | |
| 700 | 1 | _aVoillet, François | |
| 700 | 1 | _aThomas, Guillemette | |
| 700 | 1 | _aSomma, Claude | |
| 700 | 1 | _aSecq, Véronique | |
| 700 | 1 | _aFarnarier, Catherine | |
| 700 | 1 | _aPayan, Marie-Josée | |
| 700 | 1 | _aDonati, Stéphanie-Yannis | |
| 700 | 1 | _aPerrin, Gilles | |
| 700 | 1 | _aTrousse, Delphine | |
| 700 | 1 | _aDizier, Stéphanie | |
| 700 | 1 | _aChiche, Laurent | |
| 700 | 1 | _aBaumstarck, Karine | |
| 700 | 1 | _aRoch, Antoine | |
| 700 | 1 | _aPapazian, Laurent | |
| 773 | 0 |
_tIntensive care medicine _gvol. 41 _gno. 1 _gp. 1-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00134-014-3524-0 _zAvailable from publisher's website |
| 999 |
_c24314816 _d24314816 |
||